Fig. 5From: Altered gut mycobiome in patients with end-stage renal disease and its correlations with serum and fecal metabolomesGut mycobiome-based classification of the ESRD patients and healthy controls. A Random forest model for discriminating patients and controls based on gut fungal profiles at the species levels. The area under the receiver-operating characteristic curve (AUC) and 95% confidence interval (CI) are shown. B Mean decrease in accuracy of the most 15 important fungal species in the random forest modelBack to article page